Talk:Case 52: Difference between revisions
Jump to navigation
Jump to search
? broader range of IHC for this case |
m ? broader range of IHC for this case |
||
| Line 1: | Line 1: | ||
The list of IHC for which Dr Torres asks why includes the following choices that I think are reasonable | The list of IHC for which Dr Torres asks why includes the following choices that I think are reasonable | ||
CD56 - generally considered the most sensitive neuroendocrine marker (and least specific), routinely we use CD56, synaptophysin, CrgA, and... | *CD56 - generally considered the most sensitive neuroendocrine marker (and least specific), routinely we use CD56, synaptophysin, CrgA, and... | ||
Ki67 - useful for assessing mitotic activity in typical vs atypical carcinoids | *Ki67 - useful for assessing mitotic activity in typical vs atypical carcinoids | ||
PanCK or AE1/AE3: Given the differential includes an adeno I think a cytokeratin would be reasonable | *PanCK or AE1/AE3: Given the differential includes an adeno I think a cytokeratin would be reasonable | ||
Revision as of 10:33, 22 May 2017
The list of IHC for which Dr Torres asks why includes the following choices that I think are reasonable
- CD56 - generally considered the most sensitive neuroendocrine marker (and least specific), routinely we use CD56, synaptophysin, CrgA, and...
- Ki67 - useful for assessing mitotic activity in typical vs atypical carcinoids
- PanCK or AE1/AE3: Given the differential includes an adeno I think a cytokeratin would be reasonable